COLGATE TOTAL ADVANCED HEALTH GUM DEFENSE TOOTHPASTE

Land: Canada

Taal: Engels

Bron: Health Canada

Werkstoffen:

SODIUM FLUORIDE; TRICLOSAN

Beschikbaar vanaf:

COLGATE-PALMOLIVE CANADA INC

ATC-code:

A01AA51

INN (Algemene Internationale Benaming):

SODIUM FLUORIDE, COMBINATIONS

Dosering:

0.243%; 0.300%

farmaceutische vorm:

TOOTHPASTE

Samenstelling:

SODIUM FLUORIDE 0.243%; TRICLOSAN 0.300%

Toedieningsweg:

DENTAL

Eenheden in pakket:

18/85/125/170ML

Prescription-type:

OTC

Therapeutisch gebied:

DENTAL AGENTS

Product samenvatting:

Active ingredient group (AIG) number: 0224632001; AHFS:

Autorisatie-status:

CANCELLED POST MARKET

Autorisatie datum:

2019-08-01

Productkenmerken

_ _
_Page 1 of 20_
PRODUCT MONOGRAPH
COLGATE TOTAL
Triclosan and Sodium Fluoride Toothpaste
0.3% Triclosan and 0.243% Sodium Fluoride
Control Number 130592, DIN 02044730
COLGATE TOTAL ADVANCED HEALTH
Triclosan and Sodium Fluoride Toothpaste
0.3% Triclosan and 0.243% Sodium Fluoride
Control Number 123143, DIN 02285568
COLGATE TOTAL ADVANCED HEALTH GUM DEFENSE
Triclosan and Sodium Fluoride Toothpaste
0.3% Triclosan and 0.243% Sodium Fluoride
Control Number 144026, DIN 02364786
Anticaries – Antiplaque – Antigingivitis - Anticalculus
Colgate-Palmolive Canada Inc.
Two Morneau Sobeco Centre, 6
th
Floor
895 Don Mills Road
Toronto, Ontario
M3C 1W3
Date of Revision:
June 25, 2013
Control Number: 163763
_ _
_Page 2 of 20_
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
................................................... 3
SUMMARY PRODUCT INFORMATION
.............................................................. 3
INDICATIONS AND CLINICAL USE
.................................................................... 3
CONTRAINDICATIONS
.......................................................................................
3
WARNINGS AND PRECAUTIONS
......................................................................
3
ADVERSE REACTIONS
......................................................................................
4
DOSAGE AND ADMINISTRATION
......................................................................
4
OVERDOSAGE
....................................................................................................
4
ACTION AND CLINICAL PHARMACOLOGY
....................................................... 5
STORAGE AND
STABILITY.................................................................................
7
SPECIAL HANDLING INSTRUCTIONS
............................................................... 7
DOSAGE FORMS, COMPOSITION AND PACKAGING
...................................... 7
PART II: SCIENTIFIC INFORMATION
..........................................................................
8
PHARMACEU